The panel voted 21 to zero that Beyfortus (nirsevimab) appears to be safe and effective at preventing RSV infections in newborns and infants as they face their first RSV season, setting the drug ...

The final obstacle to the routine use of Sanofi and AstraZeneca's Beyfortus to prevent respiratory syncytial virus (RSV) in the US has fallen after it was backed by Centres for Disease Control and ...

Japan's parliament on Friday raised the age of sexual consent to 16 from 13, a limit which had remained unchanged for more than a century and was among the world's lowest, amid calls for greater ...